On 25 October 2024, Commission Implementing Regulation (EU) 2024/2750 [Commission Implementing Regulation (EU) 2024/2750 of 25 October 2024 granting a Union authorisation for the biocidal product family LANXESS CMIT/MIT biocidal product family in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2024/2750, 28.10.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2750/oj).] granted a Union authorisation, under number EU-0031652-0000, to Lanxess Deutschland GmbH for the making available on the market and use of the biocidal product family ‘LANXESS CMIT/MIT biocidal product family’. The Annex to that Implementing Regulation provides the summary of product characteristics (‘SPC’) for that biocidal product family.
Recital 1, Regulation (EU) 2026/2024
In forcesince 10 Sep 2026